advertisement

---

Pintor J 10

Showing records 1 to 10 | Display all abstracts from Pintor J

78020 Increased ApA levels and ecto-nucleotidase activity in glaucomatous mice retina
Pérez de Lara MJ
Purinergic signalling 2018; 14: 259-270

---

78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Jacob TF; Singh V
Purinergic signalling 2018; 14: 271-284

---

78020 Increased ApA levels and ecto-nucleotidase activity in glaucomatous mice retina
Guzmán-Aranguez A
Purinergic signalling 2018; 14: 259-270

---

78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Dixit M
Purinergic signalling 2018; 14: 271-284

---

78020 Increased ApA levels and ecto-nucleotidase activity in glaucomatous mice retina
Gómez-Villafuertes R
Purinergic signalling 2018; 14: 259-270

---

78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Ginsburg-Shmuel T
Purinergic signalling 2018; 14: 271-284

---

78020 Increased ApA levels and ecto-nucleotidase activity in glaucomatous mice retina
Gualix J
Purinergic signalling 2018; 14: 259-270

---

78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Fonseca B
Purinergic signalling 2018; 14: 271-284

---

78020 Increased ApA levels and ecto-nucleotidase activity in glaucomatous mice retina
Miras-Portugal MT; Pintor J
Purinergic signalling 2018; 14: 259-270

---

78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Pintor J; Youdim MBH; Major DT; Weinreb O; Fischer B
Purinergic signalling 2018; 14: 271-284

---